Viewing Study NCT00547066

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:40 PM
Ignite Modification Date: 2026-01-04 @ 1:16 PM
Study NCT ID: NCT00547066
Status: TERMINATED
Last Update Posted: 2021-08-16
First Post: 2007-10-17
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Study of Veltuzumab (hA20) at Different Doses in Patients With ITP
Sponsor: Gilead Sciences
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Purpura, Thrombocytopenic, Idiopathic View
None Autoimmune Thrombocytopenic Purpura View
None Purpura, Thrombocytopenic, Autoimmune View
Keywords:

Keywords

Keyword Brief Keyword Text View
None ITP View
None hA20 View
None Treatment View